{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:01:16Z","timestamp":1777676476065,"version":"3.51.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.588395","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T09:05:20Z","timestamp":1605171920000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Harald","family":"Hefter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Schomaecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Schomaecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Samadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1212\/WNL.53.8.1871","article-title":"Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group","volume":"53","year":"1999","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Move Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Move Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3","author":"Nutt","year":"1988","journal-title":"Move Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s004150070094","volume":"247","year":"2000","journal-title":"J Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/mds.870100513","article-title":"Epidemiology and outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota","volume":"10","author":"Claypool","year":"1995","journal-title":"Move Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/mds.870130613","article-title":"Effect of dystonia and botulinum toxin treatment on health-related quality of life","volume":"13","author":"Gudex","year":"1998","journal-title":"Move Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mds.10127","article-title":"Impact of cervical dystonia on quality of life","volume":"17","author":"Camfield","year":"2002","journal-title":"Move Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","article-title":"What are the determinants of quality of life in people with cervical dystonia?","volume":"72","author":"Ben-Shlomo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parkreldis.2018.07.019","article-title":"Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study","volume":"57","author":"Moll","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s004150050345","article-title":"Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group","volume":"246","author":"Kessler","year":"1999","journal-title":"J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e001853","DOI":"10.1136\/bmjopen-2012-001853","article-title":"An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)","volume":"3","author":"Hefter","year":"2013","journal-title":"BMJ Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1468-1331.2004.01053.x","article-title":"The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment","volume":"12","author":"Skogseid","year":"2005","journal-title":"Eur J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00115-012-3708-1","article-title":"Botulinum-Toxin-Therapie bei Torticollis spasmodicus","volume":"84","author":"Leplow","year":"2013","journal-title":"Der Nervenarzt"},{"key":"B16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3111\/13696998.2011.653726","article-title":"Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia","volume":"15","author":"Sethi","year":"2012","journal-title":"J Med Econ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/toxins5040776","article-title":"Continuation of long-term care for cervical dystonia at an academic movement disorders clinic","volume":"5","author":"Gill","year":"2013","journal-title":"Toxins"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/mds.10252","article-title":"Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period","volume":"17","author":"Hsiung","year":"2002","journal-title":"Move Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.toxicon.2017.09.004","article-title":"Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?","author":"Jinnah","year":"","journal-title":"Toxicon"},{"key":"B20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1212\/WNL.38.4.530","article-title":"The clinical course of spasmodic torticollis","volume":"38","author":"Lowenstein","year":"1988","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/archneur.1990.00530050070014","article-title":"Natural history of adult-onset idiopathic torticollis","volume":"47","author":"Jahanshahi","year":"1990","journal-title":"Arch Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0140-6736(71)92318-X","article-title":"Natural history of spasmodic torticollis, and effect of surgery","volume":"2","author":"Meares","year":"1971","journal-title":"Lancet"},{"key":"B23","first-page":"210","article-title":"Cervical dystonia (spasmodic torticollis). Some aspects of the natural history","volume":"95","author":"Van Zandijcke","year":"1995","journal-title":"Acta Neurol Belg"},{"key":"B24","first-page":"158","article-title":"Cervical and axial dystonia","volume-title":"Handbook of Botulinum Toxin Treatment","author":"Benecke","year":"2003"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00415-011-5961-9","article-title":"Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration","volume":"258","author":"Isaias","year":"2011","journal-title":"J Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet."},{"key":"B27","first-page":"211","article-title":"Clinical assessments of patients with cervical dystonia","volume-title":"Therapy With Botulinum Toxin","author":"Consky","year":"1994"},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fneur.2017.00035","article-title":"Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin","volume":"8","author":"Contarino","year":"2017","journal-title":"Front Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2014.12.030","article-title":"Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE)","volume":"349","author":"Jankovic","year":"2015","journal-title":"J Neurol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle Nerve"},{"key":"B31","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mdc3.12322","article-title":"High botulinum toxin-neutralizing antibody prevalence under long-term cervical dystonia treatment","volume":"3","author":"Hefter","year":"2016","journal-title":"Move Disord Clin Pract"},{"key":"B32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1179\/174313209X405137","article-title":"A long-term follow-up of botulinum toxin A in cervical dystonia","volume":"31","author":"Mohammadi","year":"2009","journal-title":"Neurol Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.20376","article-title":"Long-term botulinum toxin efficacy, safety, and immunogenicity","volume":"20","author":"Mejia","year":"2005","journal-title":"Move Disord"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51225","article-title":"Long-term adherence and response to botulinum toxin in different indications","author":"Lee","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.baga.2012.03.003","article-title":"CT-guided intramuscular botulinum toxin A injections into the deep anterior neck muscles in patients with pure antecaput or antecollis","volume":"2","author":"Hefter","year":"2012","journal-title":"Basal Ganglia."},{"key":"B36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.baga.2012.04.027","article-title":"Impact of posterior deep neck muscle treatment on cervical dystonia: necessity to differentiate between abnormal positions of head and neck","volume":"2","author":"Hefter","year":"2012","journal-title":"Basal Ganglia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/brain\/awn120","article-title":"Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration","volume":"131","author":"Isaias","year":"2008","journal-title":"Brain."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s00415-019-09681-7","article-title":"Effective long-term treatment with incobotulinumtoxin (Xeomin\u00ae) without neutralizing antibody induction: a monocentric, cross-sectional study","volume":"267","author":"Hefter","year":"2020","journal-title":"J Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1212\/WNL.0000000000006688","article-title":"High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy","volume":"92","author":"Albrecht","year":"2019","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756286419892078","article-title":"Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with vervical dystonia","volume":"12","author":"Hefter","year":"2019","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.588395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T09:05:23Z","timestamp":1605171923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.588395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":40,"alternative-id":["10.3389\/fneur.2020.588395"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.588395","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"article-number":"588395"}}